<div id="content" class="col-md-12" style="">
<div data-drupal-messages-fallback="" class="hidden"/><div id="block-medsites-page-title" class="widget block">
<h1><span property="schema:name">Pulmonary Hypertension</span>
</h1>
</div>
<div id="block-medsites-content" class="widget block">
<article data-history-node-id="2546" role="article" about="/commodorecompendium/pulmonary-hypertension" typeof="schema:WebPage">
<div>
<div property="schema:text" class="field field--name-body field--type-text-with-summary field--label-hidden field__item"><table class="TableGrid6" style="width:100.0%; border-collapse:collapse; border:none" width="100%">
<tbody>
<tr>
<td style="border-bottom:1px solid black; width:100%; padding:0in 7px 0in 0in; height:12px; border-top:2px double black; border-right:none; border-left:none">
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Pulmonary Hypertension – Kaele Leonard</span></span></b></span></span></span></p>
</td>
</tr>
</tbody>
</table>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Background</span></span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Symptoms: dyspnea, exertional chest pain, fatigue, edema (legs, abdomen), exertional lightheadedness or syncope, palpitation</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Exam: JVD, increased P2, split S2, RV heave, TR murmur, hepatomegaly, ascites, edema</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Signs of RV failure: low cardiac output (hypotension, renal failure, hepatic congestion), arrhythmias, refractory hypoxemia (R→L shunt), effusions (pericardial &gt; pleural)</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">WHO Groups and Causes:</span></span></span></span></span></li>
</ul>
<ol style="list-style-type:upper-roman">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Pulmonary arterial hypertension (PAH): obliteration of blood vessels in the lung</span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Idiopathic, heritable</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Drugs/toxins (methamphetamine)</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Associated with CTD, HIV, portal HTN, congenital heart disease, schistosomiasis</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Pulmonary veno-occlusive disease (PVOD), pulmonary capillary hemangiomatosis</span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Left heart disease: back pressure and passive congestion</span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">HFrEF, HFpEF, valvular disease, LA stiffness</span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Chronic lung disease: chronic hypoxemia </span></span><span style="font-size:12.0pt"><span style="font-family:Wingdings">à</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">chronic pulmonary vasoconstriction</span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">COPD, ILD, OSA, chronic high-altitude, developmental lung disorders</span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Pulmonary artery obstruction and thrombi: obstruction due to chronic clot material </span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Chronic thromboembolic pulmonary hypertension (CTEPH)</span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Unclear or multifactorial mechanisms</span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Hematologic disorders, chronic hemolytic anemia, sarcoidosis, pulmonary Langerhans cell histiocytosis, fibrosing mediastinitis, metabolic disorders</span></span></span></span></span></li>
</ul>
</li>
</ol>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Evaluation</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Consult pulmonary hypertension with any questions or assistance with workup. Below are studies to consider ordering to determine etiology/group of pulmonary hypertension</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Labs: BNP, rheumatologic studies (ANA, RF), HIV</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">CXR: increased right heart border, increased PA</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">EKG: RVH</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino">, RAD</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">TTE w/ bubble: RVSP &gt;35-40, RV dilation and dysfunction, RA dilation, septal flattening, pericardial effusion, evaluate for L heart disease and shunt</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">PFTs: decreased DLCO in PH, evaluate for parenchymal lung disease</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">VQ scan</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> or CTA chest: evaluate for CTEPH</span></span></span></span></span>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Pulmonary angiogram (evaluate for surgical candidacy for pulmonary endarterectomy)</span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><u><span style="font-size:12.0pt"><span style="font-family:Palatino">+</span></span></u><span style="font-size:12.0pt"><span style="font-family:Palatino"> CT chest: evaluate for parenchymal lung disease</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><u><span style="font-size:12.0pt"><span style="font-family:Palatino">+</span></span></u><span style="font-size:12.0pt"><span style="font-family:Palatino"> ABG: evaluate for hypoxemia or hypercarbia</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><u><span style="font-size:12.0pt"><span style="font-family:Palatino">+</span></span></u><span style="font-size:12.0pt"><span style="font-family:Palatino"> Sleep</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> study: evaluate for OSA</span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Right heart catheterization (RHC): diagnose PH and determine pre- vs post-capillary</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">See RHC section for hemodynamic assessment </span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Nitric oxide challenge assess for drug response</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Fluid challenge</span></span> <span style="font-size:12.0pt">→</span><span style="font-size:12.0pt"><span style="font-family:Palatino"> assess left heart compliance</span></span></span></span></span></li>
</ul>
<p style="margin-left:25px"> </p>
<table align="center" class="TableGrid6" style="width:100.0%; border-collapse:collapse; border:none" width="100%">
<tbody>
<tr>
<td style="border-bottom:1px solid black; width:33%; padding:0in 7px 0in 7px; background-color:black; border-top:1px solid black; border-right:1px solid black; border-left:1px solid black">
<p align="center" style="text-align:center"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Definitions</span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:40%; padding:0in 7px 0in 7px; background-color:black; border-top:1px solid black; border-right:1px solid black; border-left:none">
<p align="center" style="text-align:center"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino"><span style="color:white">Characteristics</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:26%; padding:0in 7px 0in 7px; background-color:black; border-top:1px solid black; border-right:1px solid black; border-left:none">
<p align="center" style="text-align:center"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino"><span style="color:white">Causes</span></span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:33%; padding:0in 7px 0in 7px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:1px solid black">
<p align="center" style="text-align:center"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino"><span style="color:black">Pre-capillary PH</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:40%; padding:0in 7px 0in 7px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none">
<p align="center" style="border:none; margin-left:12px; text-align:center; text-indent:-9.35pt"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino"><span style="color:black">mPAP &gt; 20 mmHg</span></span></span></span></span></span></p>
<p align="center" style="border:none; margin-left:12px; text-align:center; text-indent:-9.35pt"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino"><span style="color:black">PAWP ≤ 15 mmHg</span></span></span></span></span></span></p>
<p align="center" style="text-align:center"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino"><span style="color:black">PVR ≥ 3 WU</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:26%; padding:0in 7px 0in 7px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none">
<p align="center" style="text-align:center"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino"><span style="color:black">Groups 1, 3, 4, 5</span></span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:33%; padding:0in 7px 0in 7px; border-top:none; border-right:1px solid black; border-left:1px solid black">
<p align="center" style="text-align:center"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Post-capillary PH</span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:40%; padding:0in 7px 0in 7px; border-top:none; border-right:1px solid black; border-left:none">
<p align="center" style="border:none; margin-left:12px; text-align:center; text-indent:-9.35pt"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">mPAP &gt; 20 mmHg</span></span></span></span></span></p>
<p align="center" style="border:none; margin-left:12px; text-align:center; text-indent:-9.35pt"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">PAWP &gt; 15 mmHg</span></span></span></span></span></p>
<p align="center" style="text-align:center"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">PVR &lt; 3 WU</span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:26%; padding:0in 7px 0in 7px; border-top:none; border-right:1px solid black; border-left:none">
<p align="center" style="text-align:center"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Group 2</span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:33%; padding:0in 7px 0in 7px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:1px solid black">
<p align="center" style="border:none; margin-left:12px; text-align:center; text-indent:-9.35pt"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino"><span style="color:black">Combined pre- and post-</span></span></span></span></span></span></p>
<p align="center" style="text-align:center"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino"><span style="color:black">capillary PH</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:40%; padding:0in 7px 0in 7px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none">
<p align="center" style="border:none; margin-left:12px; text-align:center; text-indent:-9.35pt"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino"><span style="color:black">mPAP &gt; 20 mmHg</span></span></span></span></span></span></p>
<p align="center" style="border:none; margin-left:12px; text-align:center; text-indent:-9.35pt"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino"><span style="color:black">PAWP &gt; 15 mmHg</span></span></span></span></span></span></p>
<p align="center" style="text-align:center"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino"><span style="color:black">PVR ≥ 3 WU</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:26%; padding:0in 7px 0in 7px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none">
<p align="center" style="text-align:center"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino"><span style="color:black">Group 2, 5</span></span></span></span></span></span></p>
</td>
</tr>
</tbody>
</table>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Management</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">General: treat underlying cause; Diuretics for right heart failure; Oxygen goal SpO2 &gt; 90%</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">PAH medicines: Consult pulmonary hypertension for consideration to start or change thes</span></span></span></span></span>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Oral treatments may be used as monotherapy or in combination</span></span></span></span></span>
<ul>
<li style="margin-left: 10px;"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Calcium-channel blockers </span></span><span lang="EN" style="font-size:12.0pt" xml:lang="EN">→</span><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino"> patients with + vasoreactive challenge</span></span></span></span></span></li>
<li style="margin-left: 10px;"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">NO-cGMP enhancers: PDE5-inhibitors sildenafil or tadalafil, riociguat</span></span></span></span></span></li>
<li style="margin-left: 10px;"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Endothelin receptor antagonists (ERAs): bosentan, macitentan, ambrisenta</span></span></span></span></span></li>
<li style="margin-left: 10px;"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Prostacyclins:</span></span></span></span></span></li>
<li style="margin-left: 10px;"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Epoprostenol: IV (Veletri) or inhaled (Flolan), half-life 4 minutes</span></span></span></span></span></li>
<li style="margin-left: 10px;"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Treprostinil: IV/subcutaneous/inhaled/PO, half-life 4 hours</span></span></span></span></span></li>
<li style="margin-left: 10px;"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Iloprost: inhaled, half-life minutes</span></span></span></span></span></li>
<li style="margin-left: 10px;"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Selexipag (Uptravi): PO, half-life hours</span></span></span></span></span></li>
<li style="margin-left: 10px;"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Side effects: headache, jaw pain, flushing, diarrhea, arthralgias</span></span></span></span></span></li>
</ul>
</li>
</ul>
</li>
<li style=""><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Treatment based on NYHA functional classification:</span></span></span></span></span>
<ul>
<li style="margin-left: 10px;"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Class I: no treatment or monotherapy</span></span></span></span></span></li>
<li style="margin-left: 10px;"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Class II: monotherapy or combination oral therapy</span></span></span></span></span></li>
<li style="margin-left: 10px;"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Class III: combination oral therapy or prostacyclin</span></span></span></span></span></li>
<li style="margin-left: 10px;"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="font-family:Palatino">Class IV: prostacyclin +/- oral therapy</span></span></span></span></span></li>
</ul>
</li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Lung transplant for patients who are candidates and failing maximal medical therapy</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">V-A ECMO can be used as bridge to medical therapy or lung transplant</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Palliative</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> measures</span></span></span></span></span>
<ul>
<li><span lang="EN" style="font-size:12.0pt" xml:lang="EN"><span style="line-height:107%"><span style="font-family:Palatino">Atrial septostomy – serves as “pop-off” valve and allows for decompression of failing RV; used as definitive palliative procedure or bridge to lung transplant</span></span></span></li>
</ul>
</li>
</ul>
</div>
</div>
</article>
</div>
</div>